Contributors: Lambrechts, Diether/0000-0002-3429-302X; De Pauw , Ellen; Gommers, Beau; Ensinck, Marjolein M.; Timmerman, Stefan; De Vriendt, Silke; Bueds, Celine; Wei, Mengjie; Arnauts, Kaline; HERMANS, Florian; Ramalho, Anabela S.; Vermeulen, Francois; Dupont, Lieven; Lambrechts, Diether; Carlon, Marianne S.; Vankelecom, Hugo
نبذة مختصرة : Cystic fibrosis (CF) is a life-shortening genetic disorder, caused by mutations in the CF transmembrane conductance regulator (CFTR) protein that regulates ion and fluid transport in epithelial tissue. Female CF patients face considerable fertility challenges, with higher prevalence of deficient fertility compared to healthy women. Not much is known about the underlying causes. In particular, the pathobiology of the endometrium, the uterus' inner lining essential for pregnancy and expressing fluctuating CFTR levels during the menstrual cycle, is unexplored in CF. To address this gap, we developed organoid models from CF patient endometrium. The organoids recapitulated CF characteristics and revealed molecular and pathway differences in cycle-recapitulating hormone responses compared to healthy endometrial organoids. Furthermore, specific functional aberrations were restored by CFTR modulator treatment. To further complement human organoid models for unraveling endometrial pathobiology in CF, we also developed organoids from a genetic CF mouse model that were also found to recapitulate CF characteristics. Moreover, single-cell RNA-sequencing analysis of the CF mouse uterus revealed molecular traits in the endometrium similar to the human CF endometrium (as evidenced by its organoid model). Our study provides new endometrium models to advance our understanding of CF-associated endometrial pathobiology, particularly regarding menstrual cycle aberrations that impact fertility. This research is timely since improved CF therapeutics result in increased life expectancy, allowing more CF patients to consider starting a family. ; This work was supported by a joint grant from the Fund Alphonse-Jean Forton (King Baudouin Foundation) and Belgian CF patient association (2023-J1810150-232650). E. De Pauw (11E9321N), S. De Vriendt (1S00823N), C. Bueds (1129323 N) are supported by a PhD Fellowship from the Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen. M. Wei is supported by a PhD grant from China Scholarship Council. ...
Rights: The Author(s) 2025. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. ; info:eu-repo/semantics/openAccess
Processing Request
No Comments.